Microwave adjuvant to radiotherapy and chemotherapy for advanced lymphoma

Forty patients with intractable, recurrent Stage IV lymphoma were treated with applications of 434-MHz microwave radiation which were combined with small doses of cytotoxic drugs and/or supervoltage irradiation on an individual basis. Complete remission in 34 patients, and partial remission in four patients followed the treatment course; only two patients failed to improve. At the time of writing, 50% of these patients were alive; the average survival period being 47 months. The synergistic effect of the combination of microwave irradiation with conventional therapeutic agents is discussed.